ARCHIVES

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

June 28, 2013

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

NCI document says 2015 goal formed in 2001, long before announcement.

February 13, 2004

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

In Brief: Koprowski, Niederhuber, Engstrom Chair DCE, DCT, DCPC BSCs; Roentgen Ray Officers Named

June 19, 1987

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004